Connect with us


Ban cigarette sale during pandemic, suggests High Court



Suggesting a temporary ban on sale of cigarettes and bidis during the pandemic, the Bombay High Court  sought a response from the Centre and state government on the same along with data on Covid-19 patients addicted to smoking.


ALSO READ :  Jammu: Truck Accident At Kunjwani


The court said it was of the opinion of consideration of such a ban by the governments as the Covid-19 virus affects the lungs and weak lungs are severely affected.

The court also directed the Maharashtra government to ensure all possible steps to make Remdesivir available to Covid-19 patients, stating that the patients or relatives will not be made to run from pillar to post to find the drug.

The judges also stressed on the need for citizens to strictly follow prescribed measures and Covid-19 protocols.

While the court heard the PIL seeking effective Covid-19 management at length on Thursday, the detailed order was made available on Friday.

“We are equally concerned as to whether the persons who are affected by Covid -19 and have become critical are persons smoking cigarettes and bidis, as it is by now well-known that the Covid-19 virus affects the lungs and weak lungs are affected more severely,” the HC noted.

Observing that no information on the effect of Covid-19 on smokers was available in the public domain from the Centre or state government, the bench added, “If this is an issue which would matter and is fatal to the health of the citizens, we are of the opinion that measures would be required to be taken to ban sale of cigarettes and bidis during the pandemic time.”

A division bench of Chief Justice Dipankar Datta and Justice Girish S Kulkarni passed directions on a PIL filed by Mumbai-based lawyer Sneha Marjadi and argued through advocates Simil Purohit and Arshil Shah, alleging that insufficient facilities are leading to violation of fundamental rights of the people, including right to life and personal liberty under Article 21 of the Constitution.

The petitioner raised concerns over scarcity of Remdesivir drug, shortage of oxygen supply, Covid-19 bed management and delay in conducting RT-PCR or Rapid Antigen Tests to detect Covid infection.

The HC expressed “pain over scarcity” of Remdesivir and said that it would not have arisen except for the sudden surge in cases due to the second wave, “which was possibly not in anticipation about two months back”.

The bench ordered that Remdesivir be made available to patients directly at the hospital or a Covid centres and said, “To ensure the availability of the drug a Nodal Agent with the helpline number with adequate staff at its disposal to undertake the supply of the drug at the required hospital/Covid centre shall be appointed.”


The court noted that it would be an “absolute obligation” of the state government to keep the helpline number in operation all over Maharashtra for 24 hours.

The bench passed various other directions to the state government including a portal and a helpline number for availability of beds in all hospitals, and considering permissions for more Covid testing laboratories. Directing the state government to ensure measures for increasing and regulating oxygen supply to all hospitals, the HC asked it to notify a mechanism to identify specific needs of hospitals at different places.



Heavy floods completely damage Doda-Khellani road




Amid severe Thunderstorm alert in the UT of Jammu and Kashmir and UT of Ladakh. A major portion of the Doda-Khelani road got blocked due to heavy rainfall. Along with vehicles, ambulances got stuck on the road as well. The road has been temporarily blocked for traffic.



Continue Reading


COVID Vaccine for age group 2 to 18 years old: Details inside




Bharat Biotech

COVID Vaccine. The Subject Expert Committee (SEC) under India’s drug regulator has given its nod to Bharat Biotech for conducting phase 2 and 3 clinical trials of its Covid-19 vaccine Covaxin on children aged between 2 to 18 years old. The  COVID vaccine trial is expected to be conducted on 525 subjects at various sites, including AIIMS-Delhi, AIIMS-Patna.

On Tuesday, the Subject Expert Committee on Covid-19 of the Central Drugs Standard Control Organization (CDSCO) considered Hyderabad-based Bharat Biotech’s application seeking permission to conduct the COVID vaccine clinical trials to evaluate the safety of Covaxin vaccine among children.


READ MORE :  Dr. Jitendra Singh calls for audit for PM care Ventilators in GMC


While talking to the media an official said “After detailed discussion, the committee recommended for the conduct of proposed phase 2nd/3rd clinical trial of the whole virion inactivated coronavirus vaccine in the 2 to 18 years age group subject to the condition that the firm should submit the interim safety data of phase 2 clinical trial along with DSMB recommendations to the CDSCO before proceeding to phase 3 part of the study.

Amish Mahajan
Content Writer
JK Media

Continue Reading


Weather Update for Jammu and Kashmir: The next 48 hours will be intense




weather update

Weather Update J&K , likely to experience rain and thunderstorm

Jammu&Kashmir including Ladakh, Gilgit, Baltistan, Muzaffarabad, Himachal Pradesh, Uttarakhand, north Rajasthan, Odisha and Telangana, likely to experience rain and thunderstorm beginning from Thursday forecasted the Meteorological Department.


READ MORE :  COVID Vaccine for age group 2 to 18 years old: Details inside


The situation will remain like this till Friday. As the country celebrates Eid tomorrow it can well be said that the universe splashed rains on celebrations as people are likely to stay indoors.

Continue Reading

Covid-19 Stats

12 May 2021, 4:47 AM (GMT)

Coronavirus Stats

23,588,999 Total Cases
256,940 Death Cases
19,611,259 Recovered Cases


Latest Posts


May 2021